The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute’s Project Call 4.1, and with a total value of approximately $4.6M.

“Since our inception five years ago, we...

The National Institute for Manufacturing Biopharmaceuticals (NIIMBL) announced 17 students selected for their 2021 NIIMBL eXperience Program. The NIIMBL eXperience is offered to African American/Black, Latinx, and Native American college freshman and sophomores students from Historically Black Colleges and Universities (HBCUs) and NIIMBL member...

The NIIMBL eXperience offers college freshman and sophomores real-world insight into career possibilities in the biopharmaceutical industry through direct interactions with industry professionals. During a multi-week virtual program, students learn about the operations of large biomanufactuers, cutting-edge technologies of small companies, training...

With biologics making up about 40% of the global pipeline coupled with the rise in demand for cell and gene therapies, it is no secret the biopharma industry will need an influx of talent to meet its future workforce needs. This summer, 12 organizations had a chance to connect directly with 13 rising sophomores and juniors to begin building that...

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded $8.9 million for high-impact biopharmaceutical manufacturing projects to support the nation’s response to the COVID-19 pandemic. Authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act signed by President Donald Trump in March...